Unijules.com

ABufas PDF Print E-mail

Composition:
Per 100 gm.:
Menthol             2.8 g,
Camphor             5.5g,
Eucalyptus Oil     1.4g,
Turpentine Oil     4.7g.
Excipients q.s.    100g.

Indications:
Improvement of condition in case of colds with symptoms such as nasal block, cough, sore throat and bronchitis.

Usage Instructions:
Rub on method: Apply 2-4 times to the chest, neck and back.
Adult and children over 12 years: An amount of 2-3 teaspoons.
Children over 6 years: 1-2 teaspoons.
Children over 2 years: 1/2-1 teaspoon 2-3 times daily and do not apply on the face.

Inhalation:
Adults and children (above 6 years old only): Melt 1-2 teaspoons in ½ liter of hot (not boiling) water. Inhale the medicated vapours for 10-15 minutes. Do not heat while inhaling. Do not reheat after use. Children must be supervised during inhalation. Contraindications: Hypersensitivity to any of the ingredients, respiratory diseases with marked hypersensitivity of the airways. Do not use for inhalation if you have acute pneumonia. Do not use on damaged or inflamed skin or open wounds. Do not use on children under 2 years. Children under 6 years: Do not use for inhalation. Precautions:  Use only externally or for inhalation. Do not apply inside the nose or mouth. In case of pregnancy or breast-feeding please consult a doctor before use. Do not apply in the chest area if you are breast-feeding.

Keep out of the reach of children. Store below 30oC.

 
< Prev   Next >

UNIQUE INNOVATIONS

Other Links...

 



You are here  :Home arrow Unique Innovations arrow ABufas
Unijules Life Sciences Limited is proposing – subject to receipt of requisite approvals, market conditions and other considerations - a public issue of its equity shares. The Draft Red Herring Prospectus has been filed by the Company with SEBI and is available on SEBI website at www.sebi.gov.in as well as on the Book Running Lead Managers website www.rathi.com.

Investors should note that an investment in equity shares involves a high degree of risk and for details relating to the same, please refer to the section titled ‘Risk Factors’ of the DRHP.